Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Guardian Pharmacy Services (GRDN) Long-Term Debt Repayments (2023 - 2024)

Guardian Pharmacy Services (GRDN) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $34.2 million as the latest value for Q4 2024.

Quarterly Long-Term Debt Repayments rose 3325.0% to $34.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $37.0 million through Dec 2025, down 2.63% year-over-year, with the annual reading at $497000.0 for FY2025, 98.69% down from the prior year.
Long-Term Debt Repayments hit $34.2 million in Q4 2024 for Guardian Pharmacy Services, up from $1.4 million in the prior quarter.
In the past five years, Long-Term Debt Repayments ranged from a high of $34.2 million in Q4 2024 to a low of $1.0 million in Q4 2023.